Company Valuation: Prostatype Genomics AB

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 188.6 134.9 48.46 11.35 74.42 17.76
Change - -28.46% -64.07% -76.58% 555.78% -76.14%
Enterprise Value (EV) 1 174.2 115.8 37.84 20.33 65.07 13.99
Change - -33.5% -67.33% -46.26% 220.01% -78.5%
P/E - -8.09x -1.38x -0.19x -0.38x -0.23x
PBR 6.67x 3.76x 1.85x 0.46x 2.22x 0.67x
PEG - - -0x 0x 0x 0x
Capitalization / Revenue 146x 13,487x 71x 8.37x 374x 29.9x
EV / Revenue 135x 11,581x 55.4x 15x 327x 23.6x
EV / EBITDA -14.3x -7.49x -1.32x -0.52x -1.6x -0.38x
EV / EBIT -14.2x -7.45x -1.32x -0.52x -1.59x -0.36x
EV / FCF - - - - - -
FCF Yield - - - - - -
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 - -1,106 -1,533 -512.7 -29.1 -1.317
Distribution rate - - - - - -
Net sales 1 1.293 0.01 0.6828 1.356 0.199 0.594
EBITDA 1 -12.15 -15.46 -28.64 -39.23 -40.73 -36.75
EBIT 1 -12.25 -15.55 -28.69 -39.25 -40.85 -38.94
Net income 1 -13.69 -15.63 -29.09 -41.44 -41.05 -44.5
Net Debt 1 -14.4 -19.06 -10.62 8.985 -9.353 -3.768
Reference price 2 14,300.0000 8,940.0000 2,120.0000 95.0000 11.1000 0.3000
Nbr of stocks (in thousands) 13.2 15.1 22.9 119 6,705 59,189
Announcement Date 5/16/21 5/4/22 5/3/23 4/24/24 4/23/25 5/31/26
1SEK in Million2SEK
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 6.28M
11.42x0.37x7.54x3.31% 102B
15.21x1.86x9.27x0.68% 96.16B
-183.2x13.6x-208.13x-.--% 42.04B
16.17x1.67x10.07x2.29% 32.01B
27.14x2.37x13.44x0.79% 29.95B
25.1x2.77x14.07x1.28% 28.5B
7.25x1.43x6.24x-.--% 20.98B
28.68x5.14x21.05x2.44% 19.4B
30.57x2.87x12.92x1.45% 16.97B
Average -2.41x 3.56x -12.61x 1.36% 39B
Weighted average by Cap. -4.63x 3.01x -13.39x 1.57%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Prostatype Genomics AB

Historical PBR trend

Valuation ratios - PBR - Prostatype Genomics AB

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Prostatype Genomics AB

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Prostatype Genomics AB

  1. Stock Market
  2. Stocks
  3. PROGEN Stock
  4. Valuation Prostatype Genomics AB